Related Experiment Videos

[Mid-term and long-term outcome in newborn infants with periventricular leukomalacia (53 cases)]

M Monset-Couchard1, O de Bethmann, B Kastler

  • 1Unité de soins intensifs néonatals de Port-Royal, centre hospitalier universitaire Cochin-Port-Royal-Tarnier, université René-Descartes, Paris, France.

Pediatrie
|January 1, 1992
PubMed

Insights

Cystic periventricular leukomalacias (CPVL) in neonates can lead to neurodevelopmental sequelae. Lesion thickness, especially in posterior regions, is a key predictor of severity, more so than extent.

Area of Science:

  • Neonatal neurology
  • Pediatric neuroimaging
  • Developmental neuroscience

Context:

  • Cystic periventricular leukomalacias (CPVL) are a common finding in preterm neonates.
  • Brain ultrasonography is a primary tool for diagnosing CPVL.
  • Neurodevelopmental outcomes in affected infants require long-term monitoring.

Purpose:

  • To investigate the relationship between cystic periventricular leukomalacias (CPVL) and neurodevelopmental sequelae in neonates.
  • To determine predictors of neurodevelopmental outcomes in infants with CPVL.
  • To assess the role of lesion characteristics in predicting sequelae severity.

Summary:

  • A cohort of 53 neonates with CPVL (mean gestational age 30 weeks) underwent 3-7 year neurodevelopmental follow-up.
  • CPVL severity ranged from minor to major forms, with or without associated intraventricular hemorrhage.
  • Lesion thickness, particularly in posterior regions, was found to be a significant predictor of neurodevelopmental sequelae, more so than lesion extent.

Impact:

  • Identifies lesion thickness as a crucial factor in predicting neurodevelopmental outcomes in neonates with CPVL.
  • Highlights the importance of posterior CPVL in determining the severity of neurological deficits.
  • Informs clinical management and prognostic assessments for infants diagnosed with CPVL.

Related Concept Videos